Assembly Biosciences (ASMB) FCF Margin Growth (1y) (2018 - 2026)
Assembly Biosciences (ASMB) FCF Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Assembly Biosciences |
418.96 Mn |
192.36 Mn |
- |
-2,043.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-2,043.00 |
| Dec 31, 2025 |
3,900.00 |
| Sep 30, 2025 |
8,205.00 |
| Jun 30, 2025 |
2,649.00 |
| Mar 31, 2025 |
6,884.00 |
| Dec 31, 2024 |
-103,270.00 |
| Sep 30, 2021 |
-33,268.00 |
| Dec 31, 2020 |
-200,580.00 |
| Sep 30, 2020 |
47,025.00 |
| Jun 30, 2020 |
62,390.00 |
| Mar 31, 2020 |
3,496.00 |
| Dec 31, 2019 |
2,255.00 |
| Sep 30, 2019 |
-4,936.00 |
| Jun 30, 2019 |
-18,333.00 |
| Mar 31, 2019 |
-21,862.00 |
| Dec 31, 2018 |
-14,785.00 |
| Sep 30, 2018 |
4,072.00 |
| Jun 30, 2018 |
2,352.00 |
| Mar 31, 2018 |
-554,478.00 |
